{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:34:19Z","timestamp":1772087659640,"version":"3.50.1"},"reference-count":15,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,7,2]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Clofazimine is an antimycobacterial, anti-inflammatory agent used in the management of leprosy and multidrug-resistant (MDR) tuberculosis. It has high oral bioavailability and poor solubility because of which prolonged administration of the drug results in its accumulation as intracellular biocrystals in tissue macrophages. We describe the case of a female patient in her early 30s who was on therapy for MDR tuberculosis. She presented with streaky haemoptysis of 6\u2009months. Radiographic examination showed no abnormality in pulmonary vasculature and parenchyma. Bronchoscopy showed diffuse red-coloured flecks in tracheal and bronchial mucosa. The retrieved bronchoalveolar lavage (BAL) fluid was reddish-purple in colour. Microscopic examination of BAL fluid showed reddish clofazimine crystal deposition in alveolar macrophages. Serum and BAL clofazimine levels were performed using high performance liquid chromatography which confirmed high drug levels. She developed reddish discolouration of the skin during therapy due to clofazimine deposition. A diagnosis of pulmonary clofazimine crystal deposition syndrome causing pseudohaemoptysis was established.<\/jats:p>","DOI":"10.1136\/bcr-2024-261340","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T22:00:13Z","timestamp":1721167213000},"page":"e261340","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Clofazimine pulmonary crystal deposition syndrome: a case of pseudo haemoptysis"],"prefix":"10.1136","volume":"17","author":[{"given":"Rinoosha","family":"Rechal","sequence":"first","affiliation":[{"name":"Pulmonary medicine, Yashoda Hospital, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virender Pratibh","family":"Prasad","sequence":"additional","affiliation":[{"name":"Yashoda Hospital, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milap","family":"Shah","sequence":"additional","affiliation":[{"name":"Yashoda Hospital, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Nagarjuna","family":"Maturu","sequence":"additional","affiliation":[{"name":"Pulmonary medicine, Yashoda Hospital, Hyderabad, Telangana, India"},{"name":"Pulmonary Medicine, PGIMER, Chandigarh, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"2025082722341784000_17.7.e261340.1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5414\/CP203784","article-title":"Fatal course of clofazimine-induced pulmonary crystal deposition in a patient with melkersson-rosenthal syndrome","volume":"58","author":"Wu","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2025082722341784000_17.7.e261340.2","first-page":"144","article-title":"Hemoptysis: evaluation and management","volume":"105","author":"O\u2019Gurek","year":"2022","journal-title":"Am Fam Physician"},{"key":"2025082722341784000_17.7.e261340.3","first-page":"38","article-title":"Approach in case of hemoptysis","volume":"6","author":"Jain","year":"2009","journal-title":"Pediatr Oncall J"},{"key":"2025082722341784000_17.7.e261340.4","first-page":"47","article-title":"Red discoloration of the sputum by clofazimine simulating haemoptysis--a case report","volume":"63","author":"Girdhar","year":"1992","journal-title":"Lepr Rev"},{"key":"2025082722341784000_17.7.e261340.5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4269\/ajtmh.1974.23.1097","article-title":"Pharmacologic studies of clofazimine","volume":"23","author":"Levy","year":"1974","journal-title":"Am J Trop Med Hyg"},{"key":"2025082722341784000_17.7.e261340.6","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00032"},{"key":"2025082722341784000_17.7.e261340.7","doi-asserted-by":"publisher","DOI":"10.3109\/03602539508994208"},{"key":"2025082722341784000_17.7.e261340.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03716.x"},{"key":"2025082722341784000_17.7.e261340.9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00006454-198812000-00011","article-title":"Pulmonary clofazimine crystals in a child with acquired immunodeficiency syn- drome and disseminated mycobacterium avium-intracellulare Infec- Tion","volume":"7","author":"Hudson","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"2025082722341784000_17.7.e261340.10","first-page":"541","article-title":"Clofazimine crystals in alveolar Macrophages from a patient with the acquired immunodeficiency syndrome","volume":"116","author":"Sandler","year":"1992","journal-title":"Arch Pathol Lab Med"},{"key":"2025082722341784000_17.7.e261340.11","doi-asserted-by":"publisher","DOI":"10.1002\/dc.2840090512"},{"key":"2025082722341784000_17.7.e261340.12","first-page":"88","article-title":"Pulmonary clofazimine crystals in two patients with the acquired immunodeficiency syndrome","volume":"1","author":"Alfandari","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025082722341784000_17.7.e261340.13","doi-asserted-by":"crossref","DOI":"10.1345\/aph.18170","article-title":"Clofazimine crystals in the cytoplasm of pulmonary macrophages","volume":"33","author":"Harbeck","year":"1999","journal-title":"Ann Pharmacother"},{"key":"2025082722341784000_17.7.e261340.14","doi-asserted-by":"crossref","DOI":"10.4103\/ijmr.IJMR_2263_19","article-title":"Pulmonary Clofazimine-induced crystal-storing histiocytosis: bronchoalveolar lavage cytological diagnosis","volume":"152","author":"Divate","year":"2020","journal-title":"Indian J Med Res"},{"key":"2025082722341784000_17.7.e261340.15","first-page":"107","article-title":"Tissue levels of clofazimine in a case of leprosy","volume":"47","author":"Desikan","year":"1976","journal-title":"Lepr Rev"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-261340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:34:25Z","timestamp":1756359265000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-261340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,16]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bcr-2024-261340"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-261340","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}